http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Cryoport Receives 2023 IMAPAC Asia Pacific Cell & Gene Therapy Excellence Award
-
Cryoport Reports Second Quarter 2023 Financial Results
-
Cryoport to Report Second Quarter 2023 Financial Results on August 9, 2023
-
Cryoport (CYRX) Prelim. Q2 Results Miss Consensus
-
Cryoport Announces Certain Preliminary Results for Second Quarter & Updates 2023 Revenue Expectations
-
Cryoport (CYRX) Selected by IVFAustralia as Exclusive Supply Chain Solutions Provider
-
IVFAustralia Selects Cryoport as Exclusive Supply Chain Solutions Provider
-
Cryoport Reports First Quarter 2023 Results
-
Cryoport to Report First Quarter 2023 Financial Results on May 4, 2023
-
Cryoport (CYRX) Signs New Supply Chain Solutions Agreement with Boston IVF to Support Reproductive Material Shipments Across the U.S.
-
Cryoport Signs New Supply Chain Solutions Agreement with Boston IVF to Support Reproductive Material Shipments Across the U.S.
-
Cryoport (CYRX) Enters Multi-Year Agreement with Inception Fertility
-
Cryoport Announces Multi-Year Agreement with Inception Fertility
-
Cryoport (CYRX) Confirms No Financial Exposure to Silicon Valley Bank
-
Cryoport Confirms No Financial Exposure to Silicon Valley Bank
-
Cryoport Reports Fourth Quarter and Full Year 2022 Results
-
Cryoport to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
-
Cryoport (CYRX) Announces New Strategic Partnership with Syneos Health (SYNH)
-
Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies
-
Cryoport to Present at the J.P. Morgan 41st Annual Healthcare Conference
-
Cryoport Reports Results for the Third Quarter 2022
-
Cryoport to Report Third Quarter 2022 Financial Results on November 3, 2022
-
Cryoport Enters into Strategic Relationship with Takeda's BioLife Plasma Services
-
Cryoport Reports Results for the Second Quarter 2022
-
Cryoport to Report Second Quarter 2022 Financial Results on August 4, 2022
-
Cryoport Reports First Quarter 2022 Results
-
Cryoport to Report First Quarter 2022 Financial Results on May 5, 2022
-
Cryoport (CYRX) Acquires Cell&Co BioServices
-
Cryoport Acquires Cell&Co BioServices
-
Cryoport's MVE Biological Solutions' New Prague Manufacturing Plant Returns to Full Production
-
Cryoport (CYRX) Authorizes $100 Million Repurchase Program
-
Cryoport Authorizes $100 Million Repurchase Program
-
Blackstone Names Ram Jagannath Global Head of Healthcare Investing, Announces Key Healthcare Sector Promotions
-
Cryoport Reports Fourth Quarter and Full Year 2021 Results
-
Cryoport Report's Fourth Quarter and 2021 Financial Results on February 24, 2022
-
Cryoport Provides Positive Update on MVE Biological Solution's New Prague Facility
-
Cryoport (CYRX) Reports Fire Damage at MVE's New Prague Facility
-
Cryoport Reports Fire Damage at MVE's New Prague Facility
-
Cryoport (CYRX) Partners with Cell Matters
-
Cryoport and Cell Matters Enter into Strategic Partnership
-
Cryoport to Present at the J.P. Morgan 40th Annual Healthcare Conference
-
Cryoport Reports Record Third Quarter and Nine Months Revenue for 2021
-
CRYOPDP, a Cryoport Company, Receives 2021 Europe Bioprocessing Excellence Award from IMAPAC
-
Cryoport to Report Third Quarter 2021 Financial Results on November 4, 2021
-
Cryoport (CYRX), Mitsubishi Logistics Corporation Partner to Bring Temperature-Controlled Supply Chain Solutions to Asia-Pacific
-
Cryoport and Mitsubishi Logistics Corporation Partner to Bring Temperature-Controlled Supply Chain Solutions to Asia-Pacific
-
Cryoport Reports Record Second Quarter 2021 Revenue
-
Cryoport to Report Second Quarter 2021 Financial Results on August 5, 2021
-
Cellenkos® Selects Cryoport to Support On-Demand, Flexible COVID-19 Therapy Shipments to Patients in Need
-
Cryoport Further Expands its Asia Pacific Operations with New Global Logistics Center in Singapore

